Unknown

Dataset Information

0

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.


ABSTRACT: P2 purinergic receptors are overexpressed in certain cancer tissues, but the pathophysiologic relevance of purinergic signaling in hepatocellular carcinoma (HCC) remains unknown. To examine the role of P2 purinergic signaling in the pathogenesis of HCC and characterize extracellular nucleotide effects on HCC cell proliferation, two independent HCC patient cohorts were analyzed for P2 purinergic receptor expression, and nucleotide treated HCC cell lines were evaluated for effects on proliferation and cell cycle progression. Our studies suggest that multiple P2 purinergic receptor isoforms are overexpressed in liver tumors, as compared to uninvolved liver, and dysregulation of P2 purinergic receptor expression is apparent in HCC cell lines, as compared to human primary hepatocytes. High P2X3 purinergic receptor expression is associated with poor recurrence-free survival (RFS), while high P2Y13 expression is associated with improved RFS. Extracellular nucleotide treatment alone is sufficient to induce cell cycle progression, via activation of JNK signaling, and extracellular ATP-mediated activation of P2X3 receptors promotes proliferation in HCC cells.Our analysis of HCC patient livers and HCC cells in vitro identifies a novel role for dysregulation of P2 purinergic signaling in the induction of hyper-proliferative HCC phenotype and identifies P2X3 purinergic receptors as potential new targets for therapy.

SUBMITTER: Maynard JP 

PROVIDER: S-EPMC4747397 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.

Maynard Janielle P JP   Lee Ju-Seog JS   Sohn Bo Hwa BH   Yu Xiaoying X   Lopez-Terrada Dolores D   Finegold Milton J MJ   Goss John A JA   Thevananther Sundararajah S  

Oncotarget 20151201 38


<h4>Unlabelled</h4>P2 purinergic receptors are overexpressed in certain cancer tissues, but the pathophysiologic relevance of purinergic signaling in hepatocellular carcinoma (HCC) remains unknown. To examine the role of P2 purinergic signaling in the pathogenesis of HCC and characterize extracellular nucleotide effects on HCC cell proliferation, two independent HCC patient cohorts were analyzed for P2 purinergic receptor expression, and nucleotide treated HCC cell lines were evaluated for effec  ...[more]

Similar Datasets

| S-EPMC6642482 | biostudies-literature
| S-EPMC8176619 | biostudies-literature
| S-EPMC6178942 | biostudies-literature
| S-EPMC8027117 | biostudies-literature
| S-EPMC6121165 | biostudies-literature
| S-EPMC6825747 | biostudies-literature
| S-EPMC4319970 | biostudies-literature
| S-EPMC5768379 | biostudies-literature
| S-EPMC6148245 | biostudies-literature
| S-EPMC2394459 | biostudies-other